Wallerian degeneration: A major component of early axonal pathology in multiple sclerosis

Brain Pathology

Volumn 20, Issue 5, 2010, Pages 976-985

  Dziedzic, Tomasz ^a,b   Metz, Imke ^a   Dallenga, Tobias ^a   König, Fatima Barbara ^a   Müller, Sven ^a   Stadelmann, Christine ^a   Brück, Wolfgang ^a  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

^b JAGIELLONIAN UNIVERSITY   (Poland)

Author keywords

axonal damage; multiple sclerosis; Wallerian degeneration; white matter

Indexed keywords

NEUROPEPTIDE Y RECEPTOR;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CONTROLLED STUDY; DISABILITY; FEMALE; HISTOPATHOLOGY; HUMAN; IMMUNOPATHOLOGY; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; NERVE DEGENERATION; NEUROFILAMENT; WHITE MATTER;

ADOLESCENT; ADULT; AGED; AMYLOID BETA-PROTEIN PRECURSOR; ANIMALS; AXONS; CHILD; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; FEMALE; HUMANS; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; NERVE FIBERS, MYELINATED; NEUROFILAMENT PROTEINS; PERIPHERAL NERVES; RECEPTORS, NEUROPEPTIDE Y; STATISTICS, NONPARAMETRIC; WALLERIAN DEGENERATION; YOUNG ADULT;

EID: 77955132553     PISSN: 10156305     EISSN: 17503639     Source Type: Journal    
DOI: 10.1111/j.1750-3639.2010.00401.x     Document Type: Article

References (36)

1. Bitsch A, Schuchardt J, Bunkowski S, Kuhlmann T, Brück W (2000) Acute axonal injury in multiple sclerosis: correlation with demyelination and inflammation. Brain 123 : 1174 1183.
2. Bjartmar C, Kidd G, Mörk S, Rudick R, Trapp BD (2000) Neurological disability correlates with spinal cord axonal loss and reduced N-acetyl aspartate in chronic multiple sclerosis patients. Ann Neurol 48 : 893 901.
3. Bjartmar C, Kinkel RP, Kidd G, Rudick RA, Trapp BD (2001) Axonal loss in normal-appearing white matter in a patient with acute MS. Neurology 57 : 1248 1252.
4. Bramlett HM, Kraydieh S, Green EJ, Dietrich WD (1997) Temporal and regional patterns of axonal damage following traumatic brain injury: a beta-amyloid precursor protein immunocytochemical study in rats. J Neuropathol Exp Neurol 56 : 1132 1141.
5. Brück W, Porada P, Poser S, Rieckmann P, Hanefeld F, Kretzschmar HA, Lassmann H (1995) Monocyte/macrophage differentiation in early multiple sclerosis lesions. Ann Neurol 38 : 788 796.
6. 1HMRS study. J Neurol 250 : 22 28.
7. Charles P, Reynolds R, Seilhean D, Rougon G, Aigrot MS, Niezgoda A et al (2002) Re-expression of PSA-NCAM by demyelinated axons: an inhibitor of remyelination in multiple sclerosis? Brain 125 : 1972 1979.
8. Ciccarelli O, Werring DJ, Barker GJ, Griffin CM, Wheeler-Kingshott CAM, Miller DH, Thompson AJ (2003) A study of the mechanisms of normal-appearing white matter damage in multiple sclerosis using diffusion tensor imaging: evidence of Wallerian degeneration. J Neurol 250 : 287 292.
9. Coman I, Aigrot MS, Seilhean D, Reynolds R, Girault JA, Zalc B, Lubetzki C (2006) Nodal, paranodal and juxtaparanodal axonal proteins during demyelination and remyelination in multiple sclerosis. Brain 129 : 3186 3195.
10. DeLuca GC, Williams K, Evangelou N, Ebers GC, Esiri MM (2006) The contribution of demyelination to axonal loss in multiple sclerosis. Brain 129 : 1507 1516.
11. De Stefano N, Narayanan S, Francis SJ, Smith S, Mortilla M, Tartaglia MC et al (2002) Diffuse axonal and tissue injury in patients with multiple sclerosis with low cerebral lesion load and no disability. Arch Neurol 59 : 1565 1571.
12. Dutta R, Trapp BD (2007) Pathogenesis of axonal and neuronal damage in multiple sclerosis. Neurology 68 (Suppl. 3 S22 S31.
13. Evangelou N, Esiri MM, Smith S, Palace J, Matthews PM (2000) Quantitative pathological evidence for axonal loss in normal appearing white matter in multiple sclerosis. Ann Neurol 47 : 391 395.
14. Evangelou N, Konz D, Esiri MM, Smith S, Palace J, Matthews PM (2000) Regional axonal loss in the corpus callosum correlates with cerebral white matter lesion volume and distribution in multiple sclerosis. Brain 123 : 1845 1849.
15. Evangelou N, Konz D, Esiri MM, Smith S, Palace J, Matthews PM (2001) Size-selective neuronal changes in the anterior optic pathways suggest a differential susceptibility to injury in multiple sclerosis. Brain 124 : 1813 1820.
16. Ferguson B, Matyszak MK, Esiri MM, Perry VH (1997) Axonal damage in acute multiple sclerosis lesions. Brain 120 : 393 399.
17. Filippi M (2001) Linking structural, metabolic and functional changes in multiple sclerosis. Eur J Neurol 8 : 291 297.
18. Filippi M, Bozzali M, Rovaris M, Gonen O, Kesavadas C, Ghezzi A et al (2003) Evidence for widespread axonal damage at the earliest clinical stage of multiple sclerosis. Brain 126 : 433 437.
19. Fu L, Matthews PM, De Stefano N, Worsley KJ, Narayanan S, Francis GS et al (1998) Imaging axonal damage of normal-appearing white matter in multiple sclerosis. Brain 121 : 103 113.
20. Ganter P, Prince C, Esiri MM (1999) Spinal cord axonal loss in multiple sclerosis: a post-mortem study. Neuropathol Appl Neurobiol 25 : 459 467.
21. Herrero-Herranz E, Pardo LA, Gold R, Linker RA (2008) Pattern of axonal injury in murine myelin oligodendrocyte glycoprotein induced experimental autoimmune encephalomyelitis: implications for multiple sclerosis. Neurobiol Dis 30 : 162 173.
22. Kornek B, Storch MK, Weissert R, Wallstroem E, Stefferl A, Olsson T et al (2000) Multiple sclerosis and chronic autoimmune encephalomyelitis: a comparative quantitative study of axonal injury in active, inactive, and remyelinated lesions. Am J Pathol 157 : 267 276.
23. Kuhlmann T, Lingfeld G, Bitsch A, Schuchardt J, Brück W (2002) Acute axonal damage in multiple sclerosis is most extensive in early disease stages and decreases over time. Brain 125 : 2202 2212.
24. Kutzelnigg A, Lucchinetti CF, Stadelmann C, Brück W, Rauschka H, Bergmann M et al (2005) Cortical demyelination and diffuse white matter injury in multiple sclerosis. Brain 128 : 2705 2712.
25. Lassmann H (1998) Pathology of multiple sclerosis. In : McAlpine's Multiple Sclerosis, A Compston, G Ebers, H Lassmann, I McDonald, B Matthews, H Wekerle (eds), pp. 323 358. Churchill Livingstone : London.
26. Lovas G, Szilagyi N, Majtenyi K, Palkovits M, Komoly S (2000) Axonal changes in chronic demyelinated cervical spinal cord plaques. Brain 123 : 308 317.
27. Lucchinetti C, Brück W, Parisi J, Scheithauer B, Rodriguez M, Lassmann H (2000) Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination. Ann Neurol 47 : 707 717.
28. Matthews PM, Arnold DL (2001) Magnetic resonance imaging of multiple sclerosis: new insights linking pathology to clinical evolution. Curr Opin Neurol 14 : 279 287.
29. Mathey EK, Derfuss T, Storch MK, Williams KR, Hales K, Woolley DR et al (2007) Neurofascin as a novel target for autoantibody-mediated axonal injury. J Exp Med 204 : 2363 2372.
30. Narayanan S, Francis SJ, Sled JG, Santos AC, Antel S, Levesque I et al (2006) Axonal injury in the cerebral normal-appearing white matter of patients with multiple sclerosis is related to concurrent demyelination in lesions but not to concurrent demyelination in normal-appearing white matter. Neuroimage 29 : 637 642.
31. Pesini P, Kopp J, Wong H, Walsh JH, Grant G, Hökfelt T (1999) An immunohistochemical marker for Wallerian degeneration of fibers in the central and peripheral nervous system. Brain Res 828 : 41 59.
32. Prineas JW (1985) The neuropathology of multiple sclerosis. In : Handbook of Clinical Neurology, PJ Vinken, GW Bruyn, HL Klawans (eds), pp. 213 257. Elsevier Sciences : Amsterdam.
33. Simon JH, Kinkel RP, Jacobs L, Bub L, Simonian N (2000) A Wallerian degeneration pattern in patients at risk for MS. Neurology 54 : 1155 1160.
34. Smith KJ (2006) Axonal protection in multiple sclerosis - a particular need during remyelination? Brain 129 : 3147 3149.
35. Trapp BD, Peterson J, Ransohoff RM, Rudick R, Mörk S, Bö L (1998) Axonal transection in the lesions of multiple sclerosis. N Engl J Med 338 : 278 285.
36. Vargas ME, Barres BA (2007) Why is Wallerian degeneration in the CNS so slow? Annu Rev Neurosci 30 : 153 179.